Drug Utilization Review (DUR) is designed to improve the quality of pharmaceutical care by ensuring that prescriptions are appropriate, medically necessary and unlikely to result in adverse medical outcomes. Medicaid’s DUR program includes prospective, online and retrospective review as well as use of standards developed by the National Council for Prescription Drug Programs (NCPDP). A board comprised of physicians and pharmacists provides guidance to Agency staff.
| January 22, 2020 |
|
July 22, 2020 |
|
| January 23, 2019 |
April 24, 2019 |
July 24, 2019 |
October 23,2019 |
| January 24, 2018 |
April 25, 2018 |
July 25, 2018 |
October 24, 2018 |
| January 25, 2017 |
April 26, 2017 |
July 26, 2017 |
October 25, 2017 |
| January 27, 2016 |
April 27, 2016 |
July 27, 2016 |
October 26, 2016 |
| January 28, 2015 |
April 22, 2015 |
July 22, 2015 |
October 28, 2015 |
| January 22, 2014 |
April 23, 2014 |
July 23, 2014 |
|